Q-omics provides the consensus-scored MIR933 profile across patient tissues and cancer cell-line models. MIR933 expression is associated with patient survival in 11 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, MIR933 is differentially expressed in 4, with the highest sampling consensus in KICH. Additionally, MIR933 RNA expression shows 8,248 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight ACC, KICH, and TGCT as cancer lineages where MIR933 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR933 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR933 survival associations across molecular data types. MIR933 RNA expression shows survival associations in the most cancer types (11). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR933 RNA expression–survival associations across cancer types. High MIR933 expression shows unfavorable associations in ACC, READ, COAD, LGG and LUSC, but favorable associations in OV. The ACC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify ACC as the clearest survival context for MIR933 RNA expression.
This table summarizes MIR933 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 4. The strongest signals are observed in KICH for RNA.
This table ranks reproducible tumor–normal expression differences for MIR933. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR933 shows lower tumor expression in KICH and THCA and higher tumor expression in LIHC and STAD. The KICH box plot shows higher MIR933 RNA expression in normal versus tumor tissue (log2 FC = −0.462, t-test p = .003).
This table shows molecular features associated with MIR933 in patient tissues and cancer cell lines. In patient samples, MIR933 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
